Genzyme Corporation · Cambridge, MA United States
| 500 Kendall St. | Phone: 617-252-7500 |
| Cambridge, MA | Fax: 617-252-7600 |
| 02142 | |
| United States | 
Map This Company |
- Company Profiles
- Competitive Landscapes
- Industry Reports
Buy Reports
For a Hoover's Free Trial, Call
(866) 444-8642or
Chat NowGenzyme Corporation Rankings
 #487 in FORTUNE 500 (May 2011) | #471 in FT Global 500 (June 2011) |
Company Description
Genzyme makes big money off uncommon diseases. The company's product portfolio focuses on treatments for rare genetic disorders, as well as kidney disease and cancer. One of its main products, Cerezyme, is a leading (and pricey) treatment for Gaucher disease, a rare enzyme-deficiency condition. Founded in 1981, Genzyme has treatments for other enzyme disorders including Fabry disease and Pompe disease. In addition, the company develops gene-based cancer treatment products, renal care and immunological therapies, organ transplant drugs, and orthopedic biosurgery products. The company was acquired by Sanofi for some $20.1 billion in 2011.
Genzyme Corporation Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Top Genzyme Corporation Competitors
More Companies in These Related Industries: Toxicology Laboratories, Pharmaceutical Preparation Mfg, Cosmetics & Toiletries Wholesalers, Biologics Mfg, Personal Safety Equipment Mfg